Acquisitions, Licensing and Other Arrangements - Kinnate Acquisition (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | ||
|---|---|---|---|
Apr. 30, 2024 |
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Asset acquisition | |||
| Exarafenib milestone contingent consideration | $ 3,307 | $ 3,214 | |
| Operating lease liabilities | 821 | $ 900 | |
| CVR Agreement | Kinnate CVR holders | |||
| Asset acquisition | |||
| Exarafenib milestone contingent consideration | $ 2,900 | $ 3,300 | |
| Kinnate | |||
| Asset acquisition | |||
| Asset acquisition, Share price (in dollars per share) | $ 2.5879 | ||
| Total purchase consideration | $ 126,400 | ||
| Operating lease liabilities | $ 800 |
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid in asset acquisition. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|